Article Details

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China ...

Retrieved on: 2021-02-12 05:37:30

Tags for this article:

Click the tags to see associated articles and topics

Apollomics, Inc. Licenses a Targeted, Active Checkpoint Control Immunotherapy for Greater China .... View article details on hiswai:

Excerpt

... including novel, humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up